{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:41:22Z","timestamp":1775018482223,"version":"3.50.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2006,4,10]],"date-time":"2006-04-10T00:00:00Z","timestamp":1144627200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2006,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Mid-ventricular obstructive hypertrophic cardiomyopathy (MVOHC) is a rare type of cardiomyopathy. The diagnosis is based on the hourglass appearance on the left ventriculogram and the presence of pressure gradient between apical and basal chamber of the ventriculum on the hemodynamic assessment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case presentation<\/jats:title>\n            <jats:p>The present case represents successful percutaneous treatment with septal ablation to patient with MVOHC associated with systolic anterior motion of the mitral valve and obstruction at both the mid-ventricular and outflow levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Alcohol septal ablation has been proposed as less invasive alternatives to surgery in patients with MVOHC.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-2261-6-15","type":"journal-article","created":{"date-parts":[[2006,4,20]],"date-time":"2006-04-20T14:35:30Z","timestamp":1145543730000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Percutaneous septal ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy: a case report"],"prefix":"10.1186","volume":"6","author":[{"given":"Istemihan","family":"Tengiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ertugrul","family":"Ercan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emin","family":"Alioglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ugur O","family":"Turk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2006,4,10]]},"reference":[{"key":"106_CR1","first-page":"199","volume":"4","author":"DM Yoerger","year":"2003","unstructured":"Yoerger DM, Weyman AE: Hypertrophic obstructive cardiomyopathy: mechanism of obstruction and response to therapy. Rev Cardiovasc Med. 2003, 4: 199-215.","journal-title":"Rev Cardiovasc Med"},{"key":"106_CR2","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S0735-1097(10)80265-7","volume":"19","author":"ED Wigle","year":"1992","unstructured":"Wigle ED, Rakowski H: Hypertrophic cardiomyopathy: when do you diagnose midventricular obstruction versus apical cavity obliteration with a small nonobliterated area at the apex of the left ventricle?. J Am Coll Cardiol. 1992, 19: 525-526.","journal-title":"J Am Coll Cardiol"},{"key":"106_CR3","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1002\/clc.4960280305","volume":"28","author":"VL Fernandes","year":"2005","unstructured":"Fernandes VL, Nagueh SF, Wang W, Roberts R, Spencer WH: A prospective follow-up of alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy \u2013 the Baylor experience (1996\u20132002). Clin Cardiol. 2005, 28: 124-130.","journal-title":"Clin Cardiol"},{"key":"106_CR4","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1053\/eupc.1998.0024","volume":"2","author":"LJ Kappenberger","year":"1999","unstructured":"Kappenberger LJ, Linde C, Jeanrenaud X, Daubert C, McKenna W, Meisel E, Sadoul N, Chojnowska L, Guize L, Gras D, Aebischer N, Gadler F, Ryden L: Clinical progress after randomized on\/off pacemaker treatment for hypertrophic obstructive cardiomyopathy. Pacing in Cardiomyopathy (PIC) Study Group. Europace. 1999, 2: 77-84. 10.1053\/eupc.1998.0024.","journal-title":"Europace"},{"key":"106_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijcard.2003.03.010","volume":"94","author":"PP Dimitrow","year":"2004","unstructured":"Dimitrow PP, Podolec P, Grodecki J, Plazak W, Dudek D, Pieniazek P, Bacior B, Legutko J, Olszowska M, Kostkiewicz M, Kawecka-Jaszcz K, Tracz W, Dubiel JS: Comparison of dual-chamber pacing with nonsurgical septal reduction effect in patients with hypertrophic obstructive cardiomyopathy. Int J Cardiol. 2004, 94: 31-34. 10.1016\/j.ijcard.2003.03.010.","journal-title":"Int J Cardiol"},{"key":"106_CR6","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1007\/s00059-005-2675-8","volume":"30","author":"FH Gietzen","year":"2005","unstructured":"Gietzen FH, Schummelfeder J, Neuser H, Brunn J, Schumacher B, Kerber S: Interventional Treatment in Hypertrophic Cardiomyopathy. Herz. 2005, 30: 102-110. 10.1007\/s00059-005-2675-8.","journal-title":"Herz"},{"key":"106_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S0735-1097(97)00508-1","volume":"31","author":"H Seggewiss","year":"1998","unstructured":"Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S: Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol. 1998, 31: 252-258. 10.1016\/S0735-1097(97)00508-1.","journal-title":"J Am Coll Cardiol"},{"key":"106_CR8","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0735-1097(10)80264-5","volume":"19","author":"T Nakamura","year":"1992","unstructured":"Nakamura T, Matsubara K, Furukawa K, Azuma A, Sugihara H, Katsume H, Nakagawa M: Diastolic paradoxic jet flow in patients with hypertrophic cardiomyopathy: Evidence of concealed apical asynergy with cavity obliteration. J Am Coll Cardiol. 1992, 19: 516-524.","journal-title":"J Am Coll Cardiol"},{"key":"106_CR9","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/S0735-1097(87)80377-7","volume":"9","author":"S Fighali","year":"1987","unstructured":"Fighali S, Krajcer Z, Edelman S, Leachman RD: Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: High incidence in patients with midventricular obstruction. J Am Coll Cardiol. 1987, 9: 288-294.","journal-title":"J Am Coll Cardiol"},{"key":"106_CR10","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0735-1097(96)00473-1","volume":"29","author":"RA Nishimura","year":"1997","unstructured":"Nishimura RA, Trusty JM, Hayes DL, Ilstrup DM, Larson DR, Hayes SN, Allison TG, Tajik AJ: Dual-chamber pacing for hypertrophic cardiomyopathy: A randomized, double blind, crossover trial. J Am Coll Cardiol. 1997, 29: 435-441. 10.1016\/S0735-1097(96)00473-1.","journal-title":"J Am Coll Cardiol"},{"key":"106_CR11","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1253\/circj.66.981","volume":"66","author":"H Watanabe","year":"2002","unstructured":"Watanabe H, Kibira S, Saito T, Shimizu H, Abe T, Nakajima I, Iino K, Miura M: Beneficial effect of dual-chamber pacing for a left mid-ventricular obstruction with apical aneurysm. Circ J. 2002, 66: 981-984. 10.1253\/circj.66.981.","journal-title":"Circ J"},{"key":"106_CR12","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1046\/j.1460-9592.2001.01639.x","volume":"24","author":"D Begley","year":"2001","unstructured":"Begley D, Mohiddin S, Fananapazir L: Dual chamber pacemaker therapy for mid-cavity obstructive hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2001, 24: 1639-1644. 10.1046\/j.1460-9592.2001.01639.x.","journal-title":"Pacing Clin Electrophysiol"},{"key":"106_CR13","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1016\/S0735-1097(01)01614-X","volume":"38","author":"SF Nagueh","year":"2001","unstructured":"Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, Danielson GK, Quinones MA, Tajik AJ, Spencer WH: Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001, 38: 1701-1706. 10.1016\/S0735-1097(01)01614-X.","journal-title":"J Am Coll Cardiol"},{"key":"106_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0025-6196(11)63224-2","volume":"76","author":"M Singh","year":"2001","unstructured":"Singh M, Edwards WD, Holmes DR, Tajil AJ, Nishimura RA: Anatomy of the first septal perforating artery: a study with implications for ablation therapy for hypertrophic cardiomyopathy. Mayo Clin Proc. 2001, 76: 799-802.","journal-title":"Mayo Clin Proc"},{"key":"106_CR15","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1053\/euje.2000.0032","volume":"1","author":"H Seggewiss","year":"2000","unstructured":"Seggewiss H, Faber L: Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction. Eur J Echocardiogr. 2000, 1: 277-280. 10.1053\/euje.2000.0032.","journal-title":"Eur J Echocardiogr"},{"key":"106_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00059-002-2371-x","volume":"27","author":"H Becher","year":"2001","unstructured":"Becher H: Contrast echocardiography: clinical applications and future prospects. Herz. 2001, 27: 201-216. 10.1007\/s00059-002-2371-x.","journal-title":"Herz"},{"key":"106_CR17","first-page":"1283","volume":"115","author":"W Zhang","year":"2002","unstructured":"Zhang W, Li Z, Zhang M, Yuan L, Guan R, Hou A, Jin Y, Deng Z: Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy. Chin Med J (Engl). 2002, 115: 1283-1286.","journal-title":"Chin Med J (Engl)"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-6-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2261-6-15\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-6-15","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2261-6-15.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T08:59:38Z","timestamp":1630486778000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/1471-2261-6-15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4,10]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,12]]}},"alternative-id":["106"],"URL":"https:\/\/doi.org\/10.1186\/1471-2261-6-15","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,4,10]]},"assertion":[{"value":"3 March 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2006","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2006","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"15"}}